Asakura, N.; Nakamura, N.; Muroi, A.; Nojima, Y.; Yamashita, T.; Kaneko, S.; Ikeda, K.; Koshikawa, N.; Suzuki, T.
Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma. Int. J. Mol. Sci. 2021, 22, 8652.
https://doi.org/10.3390/ijms22168652
AMA Style
Asakura N, Nakamura N, Muroi A, Nojima Y, Yamashita T, Kaneko S, Ikeda K, Koshikawa N, Suzuki T.
Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2021; 22(16):8652.
https://doi.org/10.3390/ijms22168652
Chicago/Turabian Style
Asakura, Nobuhiko, Naotoshi Nakamura, Atsushi Muroi, Yosui Nojima, Taro Yamashita, Shuichi Kaneko, Kazuki Ikeda, Naohiko Koshikawa, and Takashi Suzuki.
2021. "Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma" International Journal of Molecular Sciences 22, no. 16: 8652.
https://doi.org/10.3390/ijms22168652
APA Style
Asakura, N., Nakamura, N., Muroi, A., Nojima, Y., Yamashita, T., Kaneko, S., Ikeda, K., Koshikawa, N., & Suzuki, T.
(2021). Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma. International Journal of Molecular Sciences, 22(16), 8652.
https://doi.org/10.3390/ijms22168652